The Atlantic

The Man Who Smelled Like Rancid Creamed Corn to Usher In a New Scientific Era

Over the past decade, a group of HIV activists has helped pioneer gene therapy.
Source: Eben Kirksey

Updated at 6:27 p.m. ET on December 19, 2018.

When the nurse slipped the IV needle into his arm, Matt Sharp was calm. Yes, he knew the risks: As one of the first humans ever to receive the experimental treatment, he could end up with mutant cells running amok in his body. But he was too enamored of the experiment’s purpose to worry about that. For two decades, Sharp had been living with HIV. He’d watched the height of the AIDS crisis claim dozens of his friends’ and lovers’ lives. Now, he believed he was taking a step toward a cure.

A few months earlier, researchers had drawn white blood cells from Sharp’s body and manipulated his DNA with tiny molecules, deleting a single gene in each cell. He was about to receive an infusion that would reintroduce the tweaked cells back into his bloodstream. The procedure aimed to change the genetic makeup of these cells to make Sharp’s body resistant to HIV. Gene therapies like this had been tried before for other diseases, but experiments were put on hold when a young man in 1999. Sharp’s body would allow researchers to test the safety of new molecular

You're reading a preview, sign up to read more.

More from The Atlantic

The Atlantic7 min readPolitics
The Millennials-Versus-Boomers Fight Divides the Democratic Party
The United States is a fortress of gerontocracy besieged by a youth rebellion. America’s leaders are old—very old. The average age in Congress has never been higher, and our national leaders are all approaching 80. Nancy Pelosi was born in 1940, Mitc
The Atlantic6 min read
How Alanis Morissette’s Music Inspired a Trump-Era Musical
Broadway’s Jagged Little Pill addresses headline-making issues by using pop rock of the ’90s. The play’s creators say they’re honoring what those songs were always about.
The Atlantic8 min readPolitics
Nigel Farage Is Winning, Even When He’s Losing
The arch-Brexiteer won’t make major gains this election, but that doesn’t mean he hasn’t succeeded.